Mental Health Effects of Tirzepatide Tirzepatide, a dual GLP-1/GIP receptor agonist , is primarily used for managing type 2 diabetes and weight loss
Of note, AD-related pathologies prompt the activation of microglia and the release of pro-inflammatory/inflammatory cytokines, which inhibit insulin receptor substrate 1 (IRS-1) (Zheng and Wang 2021)
Storage Guide Introduction Managing a new medication can feel overwhelming, especially when that medication is a central part of your weight loss journey
After 28 days, peptide degradation accelerates and potency drops below acceptable levels
Increased heart rate: A resting heart rate that suddenly feels fast or pounding should be reported to your provider
Animal and clinical studies have shown that GLP-1RAs ameliorate liver inflammation and lower the risk of NAFLD and NASH developing into liver cancer